Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
ISSU
Penetrium Bioscience
★★
Penetrium Bioscience Announces 73.9 Billion Won Rights Offering… Dilution Inevitable but Funds Secured for Clinical Pipeline
05/27/2026, 04:27 PM
MATR
Penetrium Bioscience
★
Penetrium Bioscience Announces Rights Offering of 8.5 Million Shares for Operational Funding, Raising Dilution Concerns
05/27/2026, 03:50 PM
PERI
Penetrium Bioscience
★
Penetrium Bioscience: Q1 2026 Revenue Down, Net Loss Persists, Equity Boosted by FVOCI Gain
05/15/2026, 03:42 PM
EXCH
Penetrium Bioscience
★
Phase 1 Trial Amendment for Pembrolizumab + Penetrium™ in Refractory/Recurrent Solid Tumors
05/13/2026, 03:54 PM
ISSU
Penetrium Bioscience
★★
PenetriumBio Science Announces 73.8 Billion Won Rights Offering — Capital Raising Amid Financial Distress
05/03/2026, 07:00 AM
MATR
Penetrium Bioscience
★★
Rights Offering Decision, Allocation Ratio of 0.155 Shares per Share
05/03/2026, 07:00 AM